Biocept Inc. (BIOCQ) — Financial Flexibility Index
Latest as of June 2023:
-0.14x
Biocept Inc. (BIOCQ) has a Financial Flexibility Index of -0.14x as of June 2023. Free cash flow of $-2.99 Million (operating CF $-3.09 Million minus capex $97.00K) represents 0% of total liabilities ($21.81 Million).
Financial Flexibility Index
-0.14x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-2.99 Million
Operating CF − Capex
Total Liabilities
$21.81 Million
USD
Capital Expenditures
$97.00K
USD
Biocept Inc. Financial Flexibility Index (2019–2022)
Historical Financial Flexibility Index trend for Biocept Inc. across 4 annual periods. See Biocept Inc. (BIOCQ) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Biocept Inc. (2019–2022)
Year-by-year free cash flow to debt coverage for Biocept Inc.. For the full company profile including market capitalisation, see BIOCQ market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | -0.57x | $-12.48 Million | $-13.29 Million | $22.01 Million | ▼ -347.2% |
| 2021 | 0.23x | $5.26 Million | $3.69 Million | $22.94 Million | ▲ +128.8% |
| 2020 | -0.80x | $-18.92 Million | $-19.79 Million | $23.76 Million | ▲ +76.7% |
| 2019 | -3.42x | $-22.31 Million | $-23.05 Million | $6.53 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities